(+)-pilocarpine multiple interactions EXP 6480464 Pilocarpine promotes the reaction [EGR3 protein binds to GABRA4 promoter] CTD PMID:16091474 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of EGR3 mRNA, Pilocarpine results in increased expression of EGR3 protein CTD PMID:16091474 (-)-demecolcine increases expression ISO RGD:736598 6480464 Demecolcine results in increased expression of EGR3 mRNA CTD PMID:23649840 (S)-nicotine decreases expression ISO RGD:736599 6480464 Nicotine results in decreased expression of EGR3 mRNA CTD PMID:21955143 15-acetyldeoxynivalenol increases expression ISO RGD:736598 6480464 15-acetyldeoxynivalenol results in increased expression of EGR3 mRNA CTD PMID:23792671 17beta-estradiol multiple interactions ISO RGD:736598 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of EGR3 mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol increases expression ISO RGD:736598 6480464 Estradiol results in increased expression of EGR3 mRNA CTD PMID:15159206 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736598 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of EGR3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736598 6480464 Tetrachlorodibenzodioxin results in decreased expression of EGR3 mRNA CTD PMID:17517823 , PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736599 6480464 Tetrachlorodibenzodioxin results in increased expression of EGR3 mRNA CTD PMID:16962184 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736599 6480464 Tetrachlorodibenzodioxin results in decreased expression of EGR3 mRNA CTD PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:736598 6480464 2 more ... CTD PMID:26705709 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of EGR3 mRNA CTD PMID:19643169 3-methylcholanthrene increases expression ISO RGD:736599 6480464 Methylcholanthrene results in increased expression of EGR3 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO RGD:736599 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of EGR3 mRNA CTD PMID:30951980 4-nitrophenol decreases expression ISO RGD:736599 6480464 4-nitrophenol results in decreased expression of EGR3 mRNA CTD PMID:34673133 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of EGR3 mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO RGD:736598 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of EGR3 mRNA] CTD PMID:21233418 all-trans-retinoic acid increases expression ISO RGD:736598 6480464 Tretinoin results in increased expression of EGR3 mRNA CTD PMID:15498508 , PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of EGR3 mRNA CTD PMID:16483693 antimonite multiple interactions ISO RGD:736598 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA CTD PMID:32076005 AP20187 multiple interactions ISO RGD:736598 6480464 [AP20187 results in increased activity of IGF1R protein mutant form] which results in increased expression of EGR3 mRNA CTD PMID:29330302 arsane multiple interactions ISO RGD:736598 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EGR3 mRNA, Arsenic inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:32525701 , PMID:33047385 arsane decreases expression ISO RGD:736598 6480464 Arsenic results in decreased expression of EGR3 mRNA CTD PMID:33047385 arsenic atom decreases expression ISO RGD:736598 6480464 Arsenic results in decreased expression of EGR3 mRNA CTD PMID:33047385 arsenic atom multiple interactions ISO RGD:736598 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EGR3 mRNA, Arsenic inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:32525701 , PMID:33047385 arsenite(3-) affects expression ISO RGD:736598 6480464 arsenite affects the expression of EGR3 mRNA CTD PMID:22959463 arsenite(3-) increases expression ISO RGD:736598 6480464 arsenite results in increased expression of EGR3 mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO RGD:736598 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EGR3 mRNA, Fulvestrant inhibits the reaction [arsenite results in increased expression of EGR3 mRNA] CTD PMID:31646340 , PMID:32076005 arsenous acid decreases expression ISO RGD:736598 6480464 Arsenic Trioxide results in decreased expression of EGR3 mRNA CTD PMID:26705709 bathocuproine disulfonic acid multiple interactions ISO RGD:736598 6480464 [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of EGR3 mRNA CTD PMID:15477007 benzene increases expression ISO RGD:736598 6480464 Benzene results in increased expression of EGR3 mRNA CTD PMID:19162166 , PMID:20359517 benzo[a]pyrene decreases expression ISO RGD:736599 6480464 Benzo(a)pyrene results in decreased expression of EGR3 mRNA CTD PMID:27195522 benzo[a]pyrene decreases methylation ISO RGD:736598 6480464 Benzo(a)pyrene results in decreased methylation of EGR3 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:736598 6480464 7 more ... CTD PMID:20382639 bexarotene decreases expression ISO RGD:736598 6480464 bexarotene results in decreased expression of EGR3 mRNA CTD PMID:17178900 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:736598 6480464 Diethylhexyl Phthalate results in decreased expression of EGR3 mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:736598 6480464 bisphenol A results in increased expression of EGR3 mRNA CTD PMID:15159206 more ... bisphenol A increases expression ISO RGD:736599 6480464 bisphenol A results in increased expression of EGR3 mRNA CTD PMID:30951980 bisphenol A affects methylation ISO RGD:736599 6480464 bisphenol A affects the methylation of EGR3 promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EGR3 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:736599 6480464 bisphenol F results in increased expression of EGR3 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:736599 6480464 1, 3-butadiene results in decreased expression of EGR3 mRNA CTD PMID:29038090 C.I. Natural Red 20 multiple interactions ISO RGD:736599 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of EGR3 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of EGR3 mRNA] CTD PMID:25451590 cadmium atom increases expression ISO RGD:736598 6480464 Cadmium results in increased expression of EGR3 mRNA CTD PMID:31646340 cadmium atom multiple interactions ISO RGD:736598 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EGR3 mRNA, Cadmium inhibits the reaction [Fulvestrant results in decreased expression of EGR3 mRNA] CTD PMID:31646340 , PMID:35301059 cadmium dichloride multiple interactions ISO RGD:736598 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EGR3 mRNA CTD PMID:35301059 Calcimycin increases expression ISO RGD:736599 6480464 Calcimycin results in increased expression of EGR3 mRNA CTD PMID:25451590 Calcimycin multiple interactions ISO RGD:736599 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of EGR3 mRNA] CTD PMID:25451590 calcitriol increases expression ISO RGD:736598 6480464 Calcitriol results in increased expression of EGR3 mRNA CTD PMID:16002434 chloroprene decreases expression ISO RGD:736599 6480464 Chloroprene results in decreased expression of EGR3 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:736599 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR3 gene CTD PMID:20938992 clomiphene decreases expression ISO RGD:736598 6480464 Clomiphene results in decreased expression of EGR3 mRNA CTD PMID:26865669 clozapine affects response to substance ISO RGD:736599 6480464 EGR3 protein affects the susceptibility to Clozapine CTD PMID:17637609 cocaine affects expression EXP 6480464 Cocaine affects the expression of EGR3 mRNA CTD PMID:20187946 cocaine decreases expression ISO RGD:736599 6480464 Cocaine deficiency results in decreased expression of EGR3 mRNA CTD PMID:27126842 cocaine multiple interactions EXP 6480464 [Cocaine co-treated with Cocaine deficiency] promotes the reaction [RUNX2 protein binds to EGR3 promoter] CTD PMID:30158054 cocaine increases expression EXP 6480464 Cocaine results in increased expression of EGR3 mRNA CTD PMID:16459018 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of EGR3 mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:736598 6480464 [Chelating Agents binds to Copper] which results in increased expression of EGR3 mRNA CTD PMID:31162603 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of EGR3 mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:736598 6480464 [Chelating Agents binds to Copper] which results in increased expression of EGR3 mRNA CTD PMID:31162603 copper(II) sulfate affects expression ISO RGD:736598 6480464 Copper Sulfate affects the expression of EGR3 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:736598 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:736598 6480464 Asbestos, Crocidolite results in increased expression of EGR3 mRNA CTD PMID:25351596 cyclosporin A multiple interactions ISO RGD:736599 6480464 Cyclosporine inhibits the reaction [Zymosan results in increased expression of EGR3 mRNA] CTD PMID:17312158 dexamethasone decreases expression ISO RGD:736599 6480464 Dexamethasone results in decreased expression of EGR3 mRNA CTD PMID:22733784 diarsenic trioxide decreases expression ISO RGD:736598 6480464 Arsenic Trioxide results in decreased expression of EGR3 mRNA CTD PMID:26705709 dibutyl phthalate increases expression ISO RGD:736599 6480464 Dibutyl Phthalate results in increased expression of EGR3 mRNA CTD PMID:17361019 , PMID:21266533 dichloromethane increases expression ISO RGD:736598 6480464 Methylene Chloride results in increased expression of EGR3 mRNA CTD PMID:20359517 diethylstilbestrol increases expression ISO RGD:736598 6480464 Diethylstilbestrol results in increased expression of EGR3 mRNA CTD PMID:15159206 , PMID:26865669 dimethylarsinic acid multiple interactions ISO RGD:736599 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO RGD:736599 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR3 mRNA CTD PMID:30529165 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:736598 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA CTD PMID:32076005 divanadium pentaoxide affects expression ISO RGD:736598 6480464 vanadium pentoxide affects the expression of EGR3 mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO RGD:736598 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ellagic acid decreases expression ISO RGD:736598 6480464 Ellagic Acid results in decreased expression of EGR3 mRNA CTD PMID:12002526 Enterolactone multiple interactions ISO RGD:736598 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:736598 6480464 entinostat results in decreased expression of EGR3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:736598 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGR3 mRNA CTD PMID:27188386 estriol increases expression ISO RGD:736598 6480464 Estriol results in increased expression of EGR3 mRNA CTD PMID:15159206 estrone increases expression ISO RGD:736598 6480464 Estrone results in increased expression of EGR3 mRNA CTD PMID:15159206 , PMID:26865669 ethanol decreases expression ISO RGD:736599 6480464 Ethanol results in decreased expression of EGR3 mRNA CTD PMID:21955143 ethanol affects expression ISO RGD:736599 6480464 Ethanol affects the expression of EGR3 mRNA CTD PMID:30319688 ethylbenzene increases expression ISO RGD:736598 6480464 ethylbenzene results in increased expression of EGR3 mRNA CTD PMID:20359517 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of EGR3 mRNA CTD PMID:30307764 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of EGR3 mRNA CTD PMID:17033635 folic acid multiple interactions ISO RGD:736599 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR3 gene CTD PMID:20938992 formaldehyde increases expression ISO RGD:736598 6480464 Formaldehyde results in increased expression of EGR3 mRNA CTD PMID:20655997 , PMID:28937961 fulvestrant decreases expression ISO RGD:736598 6480464 Fulvestrant results in decreased expression of EGR3 mRNA CTD PMID:26865669 , PMID:31646340 fulvestrant multiple interactions ISO RGD:736598 6480464 Cadmium inhibits the reaction [Fulvestrant results in decreased expression of EGR3 mRNA] more ... CTD PMID:31646340 genistein increases expression ISO RGD:736598 6480464 Genistein results in increased expression of EGR3 mRNA CTD PMID:15159206 , PMID:26865669 genistein decreases expression ISO RGD:736599 6480464 Genistein results in decreased expression of EGR3 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of EGR3 mRNA CTD PMID:33387578 hexestrol increases expression ISO RGD:736598 6480464 Hexestrol results in increased expression of EGR3 mRNA CTD PMID:26865669 hydroquinone increases expression ISO RGD:736598 6480464 hydroquinone results in increased expression of EGR3 mRNA CTD PMID:31256213 isotretinoin decreases expression ISO RGD:736598 6480464 Isotretinoin results in decreased expression of EGR3 mRNA CTD PMID:20436886 ivermectin multiple interactions ISO RGD:736598 6480464 ESR1 protein affects the reaction [Ivermectin results in increased expression of EGR3 mRNA] CTD PMID:33405908 ivermectin increases expression ISO RGD:736598 6480464 Ivermectin results in increased expression of EGR3 mRNA CTD PMID:33405908 L-methionine multiple interactions ISO RGD:736599 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR3 gene CTD PMID:20938992 leflunomide increases expression ISO RGD:736598 6480464 leflunomide results in increased expression of EGR3 mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:736598 6480464 licochalcone B results in increased expression of EGR3 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO RGD:736598 6480464 Lipopolysaccharides results in increased expression of EGR3 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:736598 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EGR3 mRNA CTD PMID:35811015 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of EGR3 mRNA CTD PMID:28801915 mestranol increases expression ISO RGD:736598 6480464 Mestranol results in increased expression of EGR3 mRNA CTD PMID:26865669 methoxychlor increases expression ISO RGD:736598 6480464 Methoxychlor results in increased expression of EGR3 mRNA CTD PMID:15159206 methylarsonic acid multiple interactions ISO RGD:736599 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA CTD PMID:34876320 methylmercury chloride increases expression ISO RGD:736598 6480464 methylmercuric chloride results in increased expression of EGR3 mRNA CTD PMID:23179753 , PMID:26272509 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of EGR3 mRNA CTD PMID:16809437 morphine increases expression ISO RGD:736599 6480464 Morphine results in increased expression of EGR3 mRNA CTD PMID:21955143 nicotine decreases expression ISO RGD:736599 6480464 Nicotine results in decreased expression of EGR3 mRNA CTD PMID:21955143 Nonylphenol increases expression ISO RGD:736598 6480464 nonylphenol results in increased expression of EGR3 mRNA CTD PMID:15159206 o-xylene increases expression ISO RGD:736598 6480464 2-xylene results in increased expression of EGR3 mRNA CTD PMID:20359517 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of EGR3 mRNA CTD PMID:33387578 perfluorobutanesulfonic acid multiple interactions ISO RGD:736598 6480464 perfluorobutanesulfonic acid inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:33111528 perfluorobutyric acid multiple interactions ISO RGD:736598 6480464 perfluorobutyric acid inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:33111528 perfluorohexanesulfonic acid multiple interactions ISO RGD:736598 6480464 perfluorohexanesulfonic acid inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:33111528 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:736598 6480464 perfluorooctane sulfonic acid inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:33111528 perfluoropentanoic acid multiple interactions ISO RGD:736598 6480464 perfluoropentanoic acid inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:33111528 phenylmercury acetate multiple interactions ISO RGD:736598 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGR3 mRNA CTD PMID:27188386 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of EGR3 mRNA CTD PMID:20345932 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate promotes the reaction [EGR3 protein binds to GABRA4 promoter] CTD PMID:16091474 pirinixic acid multiple interactions ISO RGD:736599 6480464 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of EGR3 mRNA] CTD PMID:17950772 pirinixic acid decreases expression ISO RGD:736599 6480464 pirinixic acid results in decreased expression of EGR3 mRNA CTD PMID:17950772 progesterone multiple interactions ISO RGD:736598 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of EGR3 mRNA CTD PMID:20660070 pyrrolidine dithiocarbamate increases expression ISO RGD:736598 6480464 pyrrolidine dithiocarbamic acid results in increased expression of EGR3 mRNA CTD PMID:15477007 pyrrolidine dithiocarbamate multiple interactions ISO RGD:736598 6480464 [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of EGR3 mRNA CTD PMID:15477007 quercetin increases expression ISO RGD:736598 6480464 Quercetin results in increased expression of EGR3 mRNA CTD PMID:21632981 raloxifene decreases expression ISO RGD:736598 6480464 Raloxifene Hydrochloride results in decreased expression of EGR3 mRNA CTD PMID:26865669 raloxifene multiple interactions ISO RGD:736598 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in increased expression of EGR3 mRNA] CTD PMID:21185374 resveratrol multiple interactions ISO RGD:736598 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of EGR3 mRNA CTD PMID:19167446 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:736598 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EGR3 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:736598 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Shikonin multiple interactions ISO RGD:736599 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of EGR3 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of EGR3 mRNA] CTD PMID:25451590 silicon dioxide increases expression ISO RGD:736598 6480464 Silicon Dioxide analog results in increased expression of EGR3 mRNA, Silicon Dioxide results in increased expression of EGR3 mRNA CTD PMID:22300531 more ... silicon dioxide increases expression ISO RGD:736599 6480464 Silicon Dioxide results in increased expression of EGR3 mRNA CTD PMID:23221170 sodium arsenate multiple interactions ISO RGD:736598 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EGR3 mRNA CTD PMID:32525701 sodium arsenate multiple interactions ISO RGD:736599 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:736598 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EGR3 mRNA CTD PMID:32076005 sodium arsenite multiple interactions ISO RGD:736599 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA CTD PMID:34876320 Soman increases expression EXP 6480464 Soman results in increased expression of EGR3 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:736599 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGR3 mRNA CTD PMID:26378955 tamibarotene increases expression ISO RGD:736598 6480464 tamibarotene results in increased expression of EGR3 mRNA CTD PMID:15498508 testosterone decreases expression ISO RGD:736599 6480464 Testosterone results in decreased expression of EGR3 mRNA CTD PMID:19693291 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of EGR3 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:736599 6480464 titanium dioxide results in decreased expression of EGR3 mRNA CTD PMID:29264374 toluene increases expression ISO RGD:736598 6480464 Toluene results in increased expression of EGR3 mRNA CTD PMID:20359517 triadimefon increases expression ISO RGD:736598 6480464 triadimefon results in increased expression of EGR3 mRNA CTD PMID:26705709 trichloroethene increases expression ISO RGD:736598 6480464 Trichloroethylene results in increased expression of EGR3 mRNA CTD PMID:20359517 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of EGR3 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:736598 6480464 trichostatin A results in increased expression of EGR3 mRNA CTD PMID:24935251 trichostatin A decreases expression ISO RGD:736598 6480464 trichostatin A results in decreased expression of EGR3 mRNA CTD PMID:24935251 , PMID:26705709 triptonide increases expression ISO RGD:736599 6480464 triptonide results in increased expression of EGR3 mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:736599 6480464 trovafloxacin results in decreased expression of EGR3 mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:736598 6480464 Valproic Acid affects the expression of EGR3 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of EGR3 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:736598 6480464 Valproic Acid results in decreased expression of EGR3 mRNA CTD PMID:24935251 , PMID:28001369 valproic acid increases expression ISO RGD:736598 6480464 Valproic Acid results in increased expression of EGR3 mRNA CTD PMID:23179753 more ... vincristine increases expression ISO RGD:736598 6480464 Vincristine results in increased expression of EGR3 mRNA CTD PMID:23649840